TSPAN14 and cancer: It remains to be determined whether targeting Tspan5 and/or Tspan14 will provide effective Notch inhibition for certain cancers in which these proteins are over-expressed, and whether such a treatment will have lower toxicity than existing anti-Notch strategies such as γ-sectretase inhibition.